Close Menu
Home » Goldman Sachs

Goldman Sachs

Feb 27, 2019

Danaher Prices $2.76B Offering of Common, Preferred Stock

Danaher is offering 11 million shares of its common stock at $123 per share and 1.5 million shares of its mandatory convertible preferred stock at $1,000 per share.

Dec 08, 2015

Goldman Sachs Upgrades Myriad, Agilent, and Thermo Fisher; Downgrades PerkinElmer, Danaher

The investment bank also raised its outlook on the life science tools sector, lowered its view of labs, and stayed steady on diagnostics.

Dec 18, 2014

Goldman Sachs Downgrades Qiagen, Bruker

The investment bank expressed doubts about Qiagen's GeneReader NGS platform, among other things, and Bruker's mixed recent record on improving its operations.

Sep 02, 2014

Goldman Sachs, Leerink Initiate Coverage of T2 Biosystems

NEW YORK (GenomeWeb) – Investment banks Goldman Sachs and Leerink Partners initiated coverage of T2 Biosystems today with a Neutral and Market Perform rating, respectively, on the firm's stock.

Jun 23, 2014

Goldman Sachs Reinstates Neutral Rating for Agilent

NEW YORK (GenomeWeb) – Goldman Sachs today reinstated a Neutral rating for Agilent Technologies with a 12-month price target on the company's shares of $58.

Jun 25, 2013

Goldman Sachs Upgrades Waters; Downgrades Agilent, Genomic Health

NEW YORK (GenomeWeb News) – Goldman Sachs today downgraded Agilent Technologies and Genomic Health, but upgraded Waters.

Apr 23, 2013

Quest Enters into Agreement to Buy Back $450M of Stock

NEW YORK (GenomeWeb News) – Quest Diagnostics has entered into an agreement with Goldman Sachs to repurchase about $450 million of its stock, the company said in a document filed with the US Securities and Exchange Commission today.

Apr 11, 2013

Goldman Sachs Upgrades Quest, LabCorp, Downgrades Sigma-Aldrich

NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs today upgraded shares of Quest Diagnostics and Laboratory Corporation of America, but downgraded Sigma-Aldrich.

Mar 28, 2013

T2 Biosystems Raises $40M

NEW YORK (GenomeWeb News) – T2 Biosystems today announced the completion of $40 million in financing to support its clinical programs and commercialization of its molecular diagnostic panel for the identification of species-specific Candida fungal infections.

Jan 16, 2013

Goldman Sachs Survey Finds Spending on Life Science Tools Remains Challenged by Funding, Fiscal Concerns

NEW YORK (GenomeWeb News) – Despite a temporary deal in Washington to avert the fiscal cliff, spending by academic research laboratories on life science research tools may remain flat in the short to medium term, according to survey results released today by Goldman Sachs.

Pages

The Scan

Australia's Gene Editing Policy Approach

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

Just "Preliminary" Work

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Some Big Trees

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

This Week in PNAS

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.